GleamWall
中文EN

VBIO Valion Bio, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1787740 · Fiscal year ends 12/31

Financial factors as of 2025-09-30 (2025Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-49.6%
TTM net income YoY-16.9%
TTM EPS YoY—
Revenue 3-yr CAGR-35.8%
Net income 3-yr CAGR—

Margins

Gross margin-58.1%
Operating margin-1,210.8%
Net margin-1,557.3%
FCF margin-1,263.5%
EBITDA margin-1,210.4%

Returns

ROE-240.3%
ROA-156.0%
ROIC (approx.)-1,514.1%
Asset turnover0.10x

Leverage & solvency

Liabilities / assets10.2%
Debt / equity0.00x
Current ratio5.86x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.81x
Accruals ratio-29.7%
Payout ratio—
Capex / revenue2.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue—$780,000
Cost of revenue—$778,000
Gross profit—$2,000
R&D expense$3.13M$1.31M
SG&A expense$4.77M$3.16M
Operating income-$7.90M-$4.48M
Interest expense$146,000$0
Pretax income$8.90M$5.70M
Income tax$0$0
Net income-$8.88M-$5.66M
EBITDA-$7.89M-$4.47M
EPS (basic)-7.84-19.68
EPS (diluted)—-19.68
Weighted avg. shares (diluted)—287,370
Banking
Net interest income—$6,000
Balance sheet
Cash & equivalents$12.64M$2.00M
Receivables—$69,000
Inventory$0$319,000
Current assets$13.01M$2.64M
PP&E, net$12.64M$2,000
Goodwill$3.46M$0
Intangibles$2.24M$0
Total assets$31.61M$2.81M
Current liabilities$646,000$272,000
Total liabilities$7.44M$272,000
Shareholders' equity$16.80M$2.54M
Shares outstanding2.53M556,902
Cash flow statement
Operating cash flow-$7.00M-$5.72M
Capital expenditure$38,000$0
Free cash flow-$7.04M-$5.72M
Investing cash flow-$705,000$0
Financing cash flow$18.35M$4.33M
Depreciation & amortization$5,000$3,000
Stock-based compensation$564,000$229,000

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.